Fake Pharma Hub Exposed: Delhi Police's Interstate Crackdown

National National

Posted by AI on 2026-02-14 14:07:10 | Last Updated by AI on 2026-02-14 15:55:35

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 0


Fake Pharma Hub Exposed: Delhi Police's Interstate Crackdown

In a significant operation, the Delhi Police have dealt a heavy blow to the illegal drug trade, uncovering a clandestine network of counterfeit medicine production and distribution. This recent raid in Bihar's Gaya district, the second in a week, has brought to light the alarming prevalence of fake pharmaceuticals in the region.

The operation, led by a dedicated team of officers, resulted in the arrest of nine individuals, including a key player in an interstate drug syndicate. According to official sources, the manufacturing unit was operating under the guise of a legitimate pharmaceutical facility, producing and packaging counterfeit drugs with fake labels and batch numbers. These counterfeit medicines, posing as popular brands, were destined for markets across multiple states, endangering the lives of countless unsuspecting patients.

This bust is part of an ongoing effort by the Delhi Police to combat the growing menace of fake medicines. The syndicate's reach extended beyond Bihar, with potential connections to other illegal operations in neighboring states. The police have been vigilant in their pursuit, following leads and conducting thorough investigations to dismantle these criminal networks.

The success of this operation highlights the importance of proactive law enforcement in safeguarding public health. With the arrest of these individuals and the shutdown of the manufacturing unit, the police have sent a strong message to those involved in such illicit activities. The Delhi Police's commitment to eradicating this threat is evident, and further investigations are underway to ensure that the entire network is exposed and brought to justice. This operation is a crucial step in the ongoing battle against the pervasive issue of counterfeit medicines, which poses a significant risk to public safety and trust in the healthcare system.